Summary
According to a post on X by @menlotimes, Oura is buying AI care startup Counsel Health for $625M. The same post lists several funding rounds. Charta Health, which automates medical chart review, billing and coding, raised a $55M Series B led by Insight Partners. Operand, which makes AI due-diligence tools for private-equity firms, raised $31M across a seed and Series A led by Khosla Ventures at a $220M valuation.
AI-assisted summary based on the listed source.
What happened
Menlo Times reports that Oura is buying AI care startup Counsel Health for $625M. Charta Health, which automates medical chart review, billing and coding, raised a $55M Series B led by Insight Partners; Operand, which makes AI due-diligence tools for private-equity firms, raised $31M across a seed and Series A led...
Why it matters
For health AI founders and investors, the Oura deal is a large acquisition of an AI care startup by a health-focused company. The funding rounds show continued investor interest in AI tools for medical administration and private-equity deal work. Readers should watch for the Oura deal's completion and for details on WhiteMatter's product, which the source does not provide.
What this means for you
Business readers can use this as a signal of where capital, competition, or market attention is moving.
Signal Intelligence
Signal Strength 95%
Technical label WATCH
Public Interest 35
Category MONEY
Reader Depth PRACTICAL
Signal Strength reflects source quality, relevance, freshness and evidence. Public Interest helps organize discovery; it is not proof of truth.
Public Interest components
Recognizable Entity Score 0
Practical Impact Score 38
Novelty Interest Score 70
Consequence Score 46
Curiosity Score 16
Shareability Score 48
Why this is here
VQV surfaced this signal because it is recent, relevant to Startup Funding, connected to Scobleizer News Pulse (X).